Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
| Autor: | McHenry CR; Department of Surgery, MetroHealth Medical Center, Cleveland, OH 44109-1998., Oppenheim DS, Murphy T, Broughan T, Vogt D, Goldfarb WB |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Surgery [Surgery] 1992 Oct; Vol. 112 (4), pp. 728-32; discussion 732-3. |
| Abstrakt: | Background: A rare kindred of familial nonmultiple endocrine neoplasia medullary thyroid carcinoma arising from a 73-year-old proband case is reported to further define this distinct entity. Methods: Twenty-four family members across four generations, four with medullary thyroid carcinoma (MTC) and two with C-cell hyperplasia (CCH), were studied. Results: Basal calcitonin levels were elevated in three patients with MTC and were normal in one patient with microscopic MTC and two patients with CCH who had persistent subtle elevation in calcium and/or pentagastrin-stimulated calcitonin levels. One patient had unilateral MTC without CCH. Associated abnormalities included papillary carcinoma (2), thyroiditis (4), adenoma (2), and colloid nodule (1). Minimum treatment was total thyroidectomy. Two patients with MTC and marked hypercalcitonemia have recurrent disease at 2.5-year and 11-year follow-up. Two patients with MTC and normal or minor elevations in basal calcitonin and two with CCH had normal provocative calcitonin testing at 6 to 18 months follow-up. Conclusions: Unilateral MTC without CCH and MTC in the elderly do not preclude a familial cause. Microscopic MTC or CCH may be seen with subtle elevations in stimulated calcitonin levels, and recognition allows for curative thyroidectomy. Other apparent dominant thyroid pathologic conditions may occur concomitantly with familial medullary thyroid carcinoma and thus routine calcitonin, and immunohistochemical testing should be performed in patients with an appropriate family history. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|